OTCMKTS:NBHGF Nobel Biocare (NBHGF) Stock Price, News & Analysis → Seven unknown AI stocks that could DOMINATE the next six years. (From The Oxford Club) (Ad) Free NBHGF Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range$18.25▼$18.2550-Day Range N/A52-Week Range$16.35▼$19.50VolumeN/AAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Nobel Biocare alerts: Email Address Ad Weiss RatingsWho are Nvidia’s Silent Partners?Nvidia recently became just the third $2 trillion company. But Nvidia can’t do everything by itself.I call these Nvidia’s “Silent Partners.” About Nobel BiocareRead More Ad Weiss RatingsWho are Nvidia’s Silent Partners?Nvidia recently became just the third $2 trillion company. But Nvidia can’t do everything by itself.I call these Nvidia’s “Silent Partners.” NBHGF Stock News HeadlinesDecember 19, 2023 | bbc.comNobel Peace Prize: Journalists Maria Ressa and Dmitry Muratov share awardDecember 17, 2023 | bbc.comNobel Prize goes to scientists behind mRNA Covid vaccinesDecember 16, 2023 | bbc.comFirst woman Physics Nobel winner in 55 yearsNovember 9, 2023 | forbes.comWill There Be A Nobel Prize For AI?October 18, 2023 | nypost.comNobel Prize winner, 64, calls his parents to tell them he won prestigious award in heartwarming momentOctober 17, 2023 | washingtonpost.comThis couple just published a Nobel winner from their living roomOctober 11, 2023 | theguardian.comNobel laureate urges Polish opposition to commit to progressive causesOctober 3, 2023 | nytimes.comWhat to Know About the 2023 Nobel PrizesJune 14, 2023 | theguardian.com‘If it’s not a risk… it’s nothing’: Nobel laureate Annie Ernaux on her unapologetic careerMay 29, 2023 | washingtonpost.comRobert E. Lucas Jr., Nobel Prize-winning economist, dies at 85April 19, 2023 | forbes.comCreative Inspiration From A Nobel Prize Winner: Bob DylanApril 11, 2023 | thetimes.co.ukAI could hasten the four-day week, says Nobel laureateApril 8, 2023 | latimes.comChatGPT opens door to four-day week, Nobel Prize winner saysMarch 17, 2023 | markets.businessinsider.comNobel laureate Paul Krugman says bailing out SVB was sensible but annoying - and calls for tougher rules to prevent more bank failuresMarch 17, 2023 | bbc.co.ukNobel scientist says 'UK research is in jeopardy'March 16, 2023 | washingtonpost.comKenzaburo Oe, lyrical novelist and Nobel laureate, dies at 88March 11, 2023 | thestreet.comNobel Economist Krugman Calls Out VenmoMarch 7, 2023 | abcnews.go.comBelarus court jails Nobel laureate Bialiatski for 10 yearsMarch 1, 2023 | news.yahoo.comOrlando advocacy group nominated for Nobel Peace PrizeFebruary 20, 2023 | theglobeandmail.comChildren’s rights advocate Landon Pearson was nominated for a Nobel Peace PrizeFebruary 18, 2023 | news.yahoo.comUkrainian Nobel winner demands justice for Russian 'war criminals'January 20, 2023 | theguardian.comSvante Pääbo: ‘It’s maybe time to rethink our idea of Neanderthals’January 5, 2023 | theguardian.comNobel-nominated vaccine expert warns of Covid complacency: ‘We’re still losing too many lives’January 4, 2023 | marketwatch.comBioinert Ceramic Market Growth and Global Share 2023 | Developing Regions, Emerging Trends and Industry Size Forecast to 2029November 16, 2022 | theguardian.comNobel peace laureate Maria Ressa: ‘In 2024, democracy could fall off a cliff’See More Headlines Receive NBHGF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Nobel Biocare and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings8/21/2014Today5/22/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Dental Equipment & Supplies Sub-IndustryN/A Current SymbolOTCMKTS:NBHGF CUSIPN/A CIKN/A Webwww.nobelbiocare.com Phone41-43-211-4200FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable Beta-0.01 The Best High-Yield Dividend Stocks for 2024Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.Get This Free Report Key CompetitorsAmerican Medical TechnologiesOTCMKTS:ADLILancer OrthodonticsOTCMKTS:LANZSartorius AktiengesellschaftOTCMKTS:SARTF180 Life SciencesNASDAQ:ATNFW1933 IndustriesOTCMKTS:TGIFFView All Competitors NBHGF Stock Analysis - Frequently Asked Questions How were Nobel Biocare's earnings last quarter? Nobel Biocare Ag (OTCMKTS:NBHGF) issued its quarterly earnings results on Thursday, August, 21st. The company reported $0.17 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.12 by $0.05. The firm had revenue of $191.67 million for the quarter, compared to the consensus estimate of $171.79 million. This page (OTCMKTS:NBHGF) was last updated on 5/22/2024 by MarketBeat.com Staff From Our PartnersElon to Transform U.S. Economy? Porter & CompanyTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 Media41 banks launch ‘crypto dollar’Stansberry ResearchTrump’s “Tax Free” Retirement Strategy Gold Safe Exchange$1,500 to $9,400 in one month? (A.I. Trade List)Prosper Trading AcademySeven unknown AI stocks that could DOMINATE the next six years.The Oxford Club[URGENT] DO NOT Touch These AI Stocks!Weiss RatingsExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nobel Biocare Ag Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
